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Methicillin-resistant Staphylococcus aureusDear Sir,
Chronic infection of the respiratory tract of patients with
cystic fibrosis with methicillin-resistant Staphylococcus aureus
(MRSA) has been shown to be associated with worse survival
[1] and a more rapid decline in FEV1 [2]. Vanderhelst et al.
defined chronic infection as three or more cultures positive for
MRSA during at least a 6 month period [2].
The implication of chronic infection with MRSA, as with
chronic Pseudomonas aeruginosa, is that once established the
patient remains infected indefinitely and suffers from repeated
exacerbations and an increased rate of decline in lung function.
The consequences for the patient are numerous. They include
isolation to reduce cross infection risks and the need for oral
and intravenous antibiotics targeted towards MRSA with
concomitant risks of allergy and toxicity. This is often
associated with significant anxiety and concern because of the
public awareness of MRSA as a “super bug”.
We believe that MRSA may behave differently to P.
aeruginosa and that patients labelled as having a ‘chronic
infection’ can return to being free of MRSA even after years of
recurrent positive cultures for MRSA. We report two children
with CF (homozygous for F508del) who stopped growing
MRSA in respiratory tract samples after a prolonged period of
culture-positivity. Whilst growingMRSA both children appeared
to have respiratory exacerbations that only responded to
antibiotics targeting MRSA.
Patient A first grew MRSA on a cough swab specimen when
3.9 years old. He continued to have respiratory tract samples
positive for MRSA until he was 9.9 years old. In total he had 22
out of 84 samples positive for MRSA and at least one positive
sample per year over a 6 year period. From 10 years old
onwards, a period of 5.2 years, all 55 respiratory tract samples
have been negative for MRSA. Eleven attempts at eradication
of MRSA were made with a variety of anti-MRSA regimens
and respiratory exacerbations were treated with antibiotics
targeting MRSA on 12 occasions. The mean BMI SD scores for
two years before, whilst and after growing MRSA were 0.14,
0.72, and 0.07 respectively. The rate of change of FEV1
whilst growing MRSA and post growing MRSA was +4.3 and
−2.4% predicted per year respectively. The clearance of
MRSA appeared to coincide with the regular growth of mucoid
P. aeruginosa and Aspergillus fumigatus in respiratory
secretions.1569-1993/$ -see front matter © 2012 European Cystic Fibrosis Society. Published
doi:10.1016/j.jcf.2012.08.004He is currently well and active. His best recent FEV1 was
81%.
Patient B first grew MRSA on a cough swab when she was
3.1 years old. Further respiratory tract samples were positive
for MRSA until age 9.8 years. In this 6.7 year period, 36 of
105 respiratory samples were positive and at least 3 samples
were positive for MRSA per year. From 9.9 years of age
onwards, a period of 4.2 years, all 31 respiratory samples
were negative for MRSA. Eleven attempts at eradication were
made and respiratory exacerbations were treated with
antibiotics targeting MRSA on seven occasions. Her mean
BMI SD scores for the two years before, during and after
growing MRSA were −0.76, −0.6, and 0.81 respectively.
The rate of change of FEV1 whilst growing MRSA and post
growing MRSA was −0.1 and −2.6% predicted per year
respectively. Interestingly patient B also grew P. aeruginosa
on 9 samples during the period of growing MRSA. After this
period and following eradication treatment she did not grow
P. aeruginosa for a further 4 years. She is currently well, and
her most recent FEV1 was 95%.
It is unlikely that these two patients had repeated re
infections from a chronic source over a prolonged period.
Family members were screened for MRSA (they were all
negative), there were no recognised environmental sources of
infection and unit procedures prevented contact between
patients.
It is important to recognise that patients may become free of
MRSA, even after years of recurrent isolation from respiratory
samples, and that the clinical impact of this infection is minimal
in some patients. Future long term longitudinal studies should
define how frequently this occurs and if there are any
associated factors with becoming free of MRSA.References
[1] Dasenbrook E, Checkley W, Merlo C, Konstan M, Lechtzin N, Boyle M.
Association between respiratory tract methicillin-resistant Staphylococcus
aureus and survival in cystic fibrosis. J Am Med Assoc 2010;303:
2386-92.
[2] Vanderhelst E, De Meirleir L, Verbanck S, Pierard D, Vincken W, Malfroot
A. Prevalence and impact on FEV1 decline of chronic methicillin-resistant
Staphylococcus aureus (MRSA) colonization in patients with cystic
fibrosis. A single-center, case control study of 165 patients. J Cyst Fibros
2012;11:2-7.by Elsevier B.V. All rights reserved.
185Letter to the EditorEvie Turner
Regional Paediatric Cystic Fibrosis Unit, Leeds Children's Hospital,
Leeds LS2 9NS, United Kingdom
Corresponding author. Tel.: +44 7971955156.
E-mail address: ea.turner@virgin.net
Keith G. Brownlee
Regional Paediatric Cystic Fibrosis Unit, Leeds Children's Hospital,
Leeds LS2 9NS, United Kingdom
E-mail address: Keith.brownlee1@leedsth.nhs.ukMiles Denton
Department of Microbiology, Leeds Children's Hospital, Leeds LS2 9NS,
United Kingdom
6 March 2012
